Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 9 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

11%

1 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

5 recruiting

Enrollment Performance

Analytics

N/A

4(57.1%)

Phase 2

2(28.6%)

Phase 4

1(14.3%)

7Total

N/A(4)

Phase 2(2)

Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (9)

Showing 9 of 9 trials

NCT05957068Not ApplicableRecruiting

Breast Cancer Exercise Intervention Study

Role: collaborator

NCT05516628Phase 2Recruiting

Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab in Resected Hepatocellular Carcinoma

Role: collaborator

NCT07019870Not ApplicableRecruiting

Screening for Early Diagnosis of Nose Cancer

Role: collaborator

NCT04946968Phase 2Active Not Recruiting

Phase-2 Dacomitinib Study on Patients With EGFR-Driven Advanced Solid Tumours With Low EGFR-AS1 IncRNA Expr or Other Novel Emerging Biomarkers

Role: collaborator

NCT06048614Not ApplicableRecruiting

Saline Enema Administration in Meconium Obstruction of Prematurity and Impact on the Resolution, Feeds, Microbiome, and Gut-brain Axis.

Role: collaborator

NCT05724264Not ApplicableRecruiting

SingapOre Lung Cancer Screening Through Integrating CT With Other biomarkErs (SOLSTICE)

Role: collaborator

NCT02418377Completed

Whole-exome Sequencing in Childhood Obesity

Role: collaborator

NCT03665961Completed

The Association Between Microbiota, Endotoxaemia and the Host Obesity/ Insulin Resistance (MiPOOP Study)

Role: collaborator

NCT03348917Phase 4Completed

The Effect of Skin Cleansers on the Skin Surface Microbiome

Role: collaborator

All 9 trials loaded